Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Lagerqvist

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Cardiology|June 17, 2010
Thrombus aspiration in ST-elevation myocardial infarction in Sweden: a short report on real world outcomeOle Fröbert, Bo Lagerqvist, Martin Kreutzer, et al.
Lancet (London, England)|September 19, 2006
5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up studyBo Lagerqvist, Steen Husted, Fredrik Kontny, et al.
The Breast Journal|January 29, 2020
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control studyAntonis Valachis, Hans Garmo, Irma Fredriksson, et al.
American Heart Journal|March 5, 2004
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarctionKristina Dunder, Lars Lind, Bo Lagerqvist, et al.
European Heart Journal|July 2, 2011
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionSasha Koul, J Gustav Smith, Fredrik Scherstén, et al.
Journal of the American College of Cardiology|May 2, 2009
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry)Ole Fröbert, Bo Lagerqvist, Jörg Carlsson, et al.
International Journal of Cardiology|February 23, 2021
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational studyIrene Santos-Pardo, Bo Lagerqvist, Viveca Ritsinger, et al.
The New England Journal of Medicine|February 14, 2007
Long-term outcomes with drug-eluting stents versus bare-metal stents in SwedenBo Lagerqvist, Stefan K James, Ulf Stenestrand, et al.
American Heart Journal|September 2, 2008
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndromeKai M Eggers, Bo Lagerqvist, Jonas Oldgren, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2011
Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndromeJonas Persson, Johan Lindbäck, Claes Hofman-Bang, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Cardiology|June 17, 2010
Thrombus aspiration in ST-elevation myocardial infarction in Sweden: a short report on real world outcomeOle Fröbert, Bo Lagerqvist, Martin Kreutzer, et al.
Lancet (London, England)|September 19, 2006
5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up studyBo Lagerqvist, Steen Husted, Fredrik Kontny, et al.
The Breast Journal|January 29, 2020
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control studyAntonis Valachis, Hans Garmo, Irma Fredriksson, et al.
American Heart Journal|March 5, 2004
Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarctionKristina Dunder, Lars Lind, Bo Lagerqvist, et al.
European Heart Journal|July 2, 2011
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionSasha Koul, J Gustav Smith, Fredrik Scherstén, et al.
Journal of the American College of Cardiology|May 2, 2009
Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry)Ole Fröbert, Bo Lagerqvist, Jörg Carlsson, et al.
International Journal of Cardiology|February 23, 2021
Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational studyIrene Santos-Pardo, Bo Lagerqvist, Viveca Ritsinger, et al.
The New England Journal of Medicine|February 14, 2007
Long-term outcomes with drug-eluting stents versus bare-metal stents in SwedenBo Lagerqvist, Stefan K James, Ulf Stenestrand, et al.
American Heart Journal|September 2, 2008
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndromeKai M Eggers, Bo Lagerqvist, Jonas Oldgren, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 27, 2011
Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndromeJonas Persson, Johan Lindbäck, Claes Hofman-Bang, et al.
Pageof 16